Entera Bio Ltd.
ENTX
$2.04
$0.052.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -48.78% | 95.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -48.78% | 95.24% | |||
| Cost of Revenue | -48.78% | 95.24% | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.76% | -26.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.69% | -21.03% | |||
| Operating Income | -9.67% | 22.64% | |||
| Income Before Tax | -9.51% | 22.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.86% | 21.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.86% | 21.95% | |||
| EBIT | -9.67% | 22.64% | |||
| EBITDA | -9.85% | 22.72% | |||
| EPS Basic | 1.82% | 24.91% | |||
| Normalized Basic EPS | 1.33% | 25.30% | |||
| EPS Diluted | 1.82% | 24.91% | |||
| Normalized Diluted EPS | 1.33% | 25.30% | |||
| Average Basic Shares Outstanding | 10.91% | 3.89% | |||
| Average Diluted Shares Outstanding | 10.91% | 3.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||